PubMed · 9873716
Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects.
Abstract
Mixed-backbone oligonucleotides containing alternative phosphorothioate and phosphodiester linkages in the 2'-O-methylribonucleosides segment show increased affinity with complementary targets, increased stability towards nucleases in vitro and in vivo, and reduced phosphorothioate-related prolongation of partial thromboplastin time compared to phosphorothioate oligodeoxynucleotides, thereby providing antisense agents with reduced side effects.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
W Zhou, S Agrawal. 1998-11-17. Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects.. https://doi.org/10.1016/s0960-894x(98)00591-5
Cite the original work for its findings. Save a collection to share your selection of sources.